Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc.

SLRX
Salarius Pharmaceuticals, Inc.US flagNASDAQ Capital Market
0.84
USD
+0.19
- -
4.92MMarket Cap

Salarius Pharmaceuticals, Inc. (SLRX) Stock Split History

Learn about Salarius Pharmaceuticals, Inc.'s most recent 1-for-15 basis stock split on August 18, 2025. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Salarius Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2025-08-18
Split Ratio: 1:15
Price Before Split: $0.45
Price After Split: $0.03

Developer API

Get SLRX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/SLRX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Salarius Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2025-08-181:15Yes$0.45$0.03
2024-06-171:8Yes$0.43$0.05
2022-10-171:25Yes$0.20$0.01
2019-07-221:25Yes$0.47$0.02

About Salarius Pharmaceuticals, Inc.

Company overview and industry information

Salarius Pharmaceuticals, Inc. (SLRX) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Salarius Pharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.